These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 16357158)

  • 1. Expression of endogenous oncogenic V600EB-raf induces proliferation and developmental defects in mice and transformation of primary fibroblasts.
    Mercer K; Giblett S; Green S; Lloyd D; DaRocha Dias S; Plumb M; Marais R; Pritchard C
    Cancer Res; 2005 Dec; 65(24):11493-500. PubMed ID: 16357158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Akt3 and mutant V600E B-Raf cooperate to promote early melanoma development.
    Cheung M; Sharma A; Madhunapantula SV; Robertson GP
    Cancer Res; 2008 May; 68(9):3429-39. PubMed ID: 18451171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting V600EB-Raf and Akt3 using nanoliposomal-small interfering RNA inhibits cutaneous melanocytic lesion development.
    Tran MA; Gowda R; Sharma A; Park EJ; Adair J; Kester M; Smith NB; Robertson GP
    Cancer Res; 2008 Sep; 68(18):7638-49. PubMed ID: 18794153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation loop phosphorylation regulates B-Raf in vivo and transformation by B-Raf mutants.
    Köhler M; Röring M; Schorch B; Heilmann K; Stickel N; Fiala GJ; Schmitt LC; Braun S; Ehrenfeld S; Uhl FM; Kaltenbacher T; Weinberg F; Herzog S; Zeiser R; Schamel WW; Jumaa H; Brummer T
    EMBO J; 2016 Jan; 35(2):143-61. PubMed ID: 26657898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of aurora kinase B and Wee1-like protein kinase as downstream targets of (V600E)B-RAF in melanoma.
    Sharma A; Madhunapantula SV; Gowda R; Berg A; Neves RI; Robertson GP
    Am J Pathol; 2013 Apr; 182(4):1151-62. PubMed ID: 23416158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inducible expression of (V600E) Braf using tyrosinase-driven Cre recombinase results in embryonic lethality.
    Dhomen N; Da Rocha Dias S; Hayward R; Ogilvie L; Hedley D; Delmas V; McCarthy A; Henderson D; Springer CJ; Pritchard C; Larue L; Marais R
    Pigment Cell Melanoma Res; 2010 Feb; 23(1):112-20. PubMed ID: 20002887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-Raf inhibits MAPK activation and transformation by B-Raf(V600E).
    Karreth FA; DeNicola GM; Winter SP; Tuveson DA
    Mol Cell; 2009 Nov; 36(3):477-86. PubMed ID: 19917255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects.
    Tuveson DA; Shaw AT; Willis NA; Silver DP; Jackson EL; Chang S; Mercer KL; Grochow R; Hock H; Crowley D; Hingorani SR; Zaks T; King C; Jacobetz MA; Wang L; Bronson RT; Orkin SH; DePinho RA; Jacks T
    Cancer Cell; 2004 Apr; 5(4):375-87. PubMed ID: 15093544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abrogation of B-Raf
    Choi YW; Nam GE; Kim YH; Yoon JE; Park JH; Kim JH; Kang SY; Park TJ
    Biochem Biophys Res Commun; 2019 Aug; 516(3):866-871. PubMed ID: 31270027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutant V599EB-Raf regulates growth and vascular development of malignant melanoma tumors.
    Sharma A; Trivedi NR; Zimmerman MA; Tuveson DA; Smith CD; Robertson GP
    Cancer Res; 2005 Mar; 65(6):2412-21. PubMed ID: 15781657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular signal-regulated kinase-dependent proliferation is mediated through the protein kinase A/B-Raf pathway in human uveal melanoma cells.
    Calipel A; Mouriaux F; Glotin AL; Malecaze F; Faussat AM; Mascarelli F
    J Biol Chem; 2006 Apr; 281(14):9238-50. PubMed ID: 16452469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting BRAFV600E in thyroid carcinoma: therapeutic implications.
    Mitsiades CS; Negri J; McMullan C; McMillin DW; Sozopoulos E; Fanourakis G; Voutsinas G; Tseleni-Balafouta S; Poulaki V; Batt D; Mitsiades N
    Mol Cancer Ther; 2007 Mar; 6(3):1070-8. PubMed ID: 17363500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-Raf(V600E) signaling deregulates the mitotic spindle checkpoint through stabilizing Mps1 levels in melanoma cells.
    Cui Y; Guadagno TM
    Oncogene; 2008 May; 27(22):3122-33. PubMed ID: 18071315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation.
    Nazarian R; Shi H; Wang Q; Kong X; Koya RC; Lee H; Chen Z; Lee MK; Attar N; Sazegar H; Chodon T; Nelson SF; McArthur G; Sosman JA; Ribas A; Lo RS
    Nature; 2010 Dec; 468(7326):973-7. PubMed ID: 21107323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of B-RAF V600E in type II pneumocytes causes abnormalities in alveolar formation, airspace enlargement and tumor formation in mice.
    Zanucco E; Götz R; Potapenko T; Carraretto I; Ceteci S; Ceteci F; Seeger W; Savai R; Rapp UR
    PLoS One; 2011; 6(12):e29093. PubMed ID: 22194995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic B-Raf(V600E) induces spindle abnormalities, supernumerary centrosomes, and aneuploidy in human melanocytic cells.
    Cui Y; Borysova MK; Johnson JO; Guadagno TM
    Cancer Res; 2010 Jan; 70(2):675-84. PubMed ID: 20068179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutationally activated PIK3CA(H1047R) cooperates with BRAF(V600E) to promote lung cancer progression.
    Trejo CL; Green S; Marsh V; Collisson EA; Iezza G; Phillips WA; McMahon M
    Cancer Res; 2013 Nov; 73(21):6448-61. PubMed ID: 24019382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional analysis of the regulatory requirements of B-Raf and the B-Raf(V600E) oncoprotein.
    Brummer T; Martin P; Herzog S; Misawa Y; Daly RJ; Reth M
    Oncogene; 2006 Oct; 25(47):6262-76. PubMed ID: 16702958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-Raf-1 protein kinase is not essential for Ras transformation of mouse embryo fibroblasts.
    Gupta AK; Bernhard EJ; Bakanauskas VJ; Cerniglia GJ; Muschel RJ; McKenna G
    Cancer Biol Ther; 2003; 2(1):73-5. PubMed ID: 12673122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial localization and regulation of BRAFV600E in thyroid cancer: a clinically used RAF inhibitor is unable to block the mitochondrial activities of BRAFV600E.
    Lee MH; Lee SE; Kim DW; Ryu MJ; Kim SJ; Kim SJ; Kim YK; Park JH; Kweon GR; Kim JM; Lee JU; De Falco V; Jo YS; Shong M
    J Clin Endocrinol Metab; 2011 Jan; 96(1):E19-30. PubMed ID: 20926530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.